Benefits Management for People With Psychiatric Disabilities
This study is currently recruiting participants.
Verified April 2011 by Yale University
Sponsor:
Yale University
Collaborators:
VA Connecticut Healthcare System
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT01329393
First received: February 2, 2011
Last updated: April 1, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This stage 1 clinical trial will determine pilot efficacy, develop a therapy manual, and collect qualitative data concerning a brief money management intervention for people disabled by psychiatric illnesses.
| Condition | Intervention | Phase |
|---|---|---|
|
Mentally Ill Chemical Abuse Schizophrenia Bipolar Disorder |
Behavioral: Benefits Management Behavioral: Illness Management and Recovery |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Benefits Management for People With Psychiatric Disabilities |
Resource links provided by NLM:
Further study details as provided by Yale University:
Primary Outcome Measures:
- Change in the Summed score on the Heinrich-Carpenter Quality of Life Measure [ Time Frame: Change from Week 0 to Week 24 ] [ Designated as safety issue: No ]The Heinrich-Carpenter Quality of Life score is derived by summing ratings of individual items after a semi-structured interview. The possible score on any given interview is 0-126. It is a global measure of social functioning with higher scores indicating better functioning.
| Estimated Enrollment: | 120 |
| Study Start Date: | August 2010 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Benefits Management
Money-management intervention consisting of brief advice on budgeting, assessment of ability to follow a budget, and assessment of need for a representative payee.
|
Behavioral: Benefits Management
Money-management intervention consisting of brief advice on budgeting, assessment of ability to follow a budget, and assessment of need for a representative payee.
|
| Active Comparator: Illness Management and Recovery |
Behavioral: Illness Management and Recovery
Recovery Oriented Training in Biopsychosocial Model of Stress and How to Cope with Stress
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Has received treatment for a psychiatric disorder within 60 days of enrollment
- Receives SSI or SSDI payments totaling at least $600 per month
- Has an identified outpatient clinician
- Either i) Homeless within the past 3 months. Homeless is defined as having spent at least seven days in a shelter, outdoors (e.g. in a park, in a car), in a public or abandoned building (e.g. train station), or temporarily (less than a continuous month) housed by family or friends OR ii) Hospitalized within the past 3 months
Justification for Inclusion Criteria: Homelessness and hospitalization are common reasons for payee assignment (Conrad, Matters et al. 1998). In a prior study, we found that a high proportion of hospitalized inpatients meet criteria for needing a payee (Rosen, Rosenheck et al. 2002a). There is no point enrolling clinically stable outpatients in this study because they are unlikely to need payees.
Exclusion Criteria:
- Already has a conservator or representative payee
- An application to assign a payee or conservator has been initiated
- Unable to speak and understand English
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01329393
Contacts
| Contact: Karen Ablondi, MPH | 2039747294 | karen.ablondi@yale.edu |
| Contact: Karen Ablondi | 2039747294 | karen.ablondi@yale.edu |
Locations
| United States, Connecticut | |
| Institute of Living | Recruiting |
| Hartford, Connecticut, United States, 06102 | |
| Contact: Karen Ablondi, MPH 203-974-7294 Karen.Ablondi@Yale.edu | |
| Principal Investigator: Charles Wilber, M.Ed. | |
Sponsors and Collaborators
Yale University
VA Connecticut Healthcare System
Investigators
| Principal Investigator: | Marc I. Rosen, M.D. | Yale University |
More Information
Additional Information:
No publications provided
| Responsible Party: | Marc I. Rosen, M.D., Yale University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT01329393 History of Changes |
| Other Study ID Numbers: | R34MH083894 |
| Study First Received: | February 2, 2011 |
| Last Updated: | April 1, 2011 |
| Health Authority: | United States: Federal Government |
Keywords provided by Yale University:
|
Disability Social Security Representative Payee |
Additional relevant MeSH terms:
|
Bipolar Disorder Schizophrenia Affective Disorders, Psychotic |
Mood Disorders Mental Disorders Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 19, 2013